For Immediate Release
January 26, 2005
www.BiodefenseStocks.com, Homeland Security Portal, Update on Biodefense Stocks and Industry: “Stockpile of smallpox vaccine builds in response to fears of a bioterror attack.”
POINT ROBERTS, WA.; January 26,2005 -www.BiodefenseStocks.com, an investor news portal for the Biodefense sector within the HomelandDefenseStocks.com (HDS) content umbrella, reports on the recent news reported by the World Health Organization (WHO) that work has begun on building a 200 million-dose stockpile of smallpox vaccine to prepare for a possible bioterror attack. Smallpox is an acute contagious disease caused by the variola virus and without vaccination we are susceptible to infection, with a thirty percent potential mortality rate. Separate from vaccines, one public company is developing a treatment countermeasure that captures smallpox related viruses and toxins directly from human blood.
Health ministers from the G7 have recently agreed to establish a bioterrorism crisis center to prepare globally against germ warfare attacks, with the WHO taking the lead in building vaccine stockpiles. A recent hypothetical smallpox attack showed the leaders of G7 countries that they are not prepared with enough smallpox vaccine in the eventuality of a biological attack.
BiodefenseStocks.com features cutting edge investor information and data on the topics of: Homeland Security Stocks, HS News, Homeland Security Investor Conferences, Links and Info on Project BioShield, Bioterrorism, Agriterrorism, Vaccines, Countermeasures to Bioterrorism, Biological & Chemical Detection, Emergency Response and Preparedness, and more.
HDS and BiodefenseStocks.com do not make recommendations, but offer unique, free information portals to investors to research news, articles, interviews and a growing list of participating public companies. HDS is compensated by sponsoring featured companies including: Aethlon Medical, Inc. (OTCBB: AEMD MDM Group, Inc. (OTC.PK: MDDM) and Markland Technologies, Inc. (OTCBB: MRKL).
BiodefenseStocks.com includes a growing list of public companies in the sector. http://www.biodefensestocks.com/BDS/Stock_List.asp
Aethlon Medical Smallpox Related Data:
Aethlon Medical, Inc. (OTCBB: AEMD) announced in December that its scientists had completed initial non-clinical human blood studies which indicate that the Hemopurifier(TM) treatment technology is effective in capturing smallpox related viruses from human blood. The studies documented that the Hemopurifier was able to capture 85% of Vaccinia from human blood in one hour and in excess of 95% during an overnight treatment study. Vaccinia is a “pox”-type virus closely related to smallpox. Related studies also indicated that the Hemopurifier was effective in removing other smallpox related viruses, including cowpox and mousepox.
“Taken together, these studies strongly indicate that the Hemopurifier(TM) will be effective in removing circulating smallpox virus from the blood of infected patients, even when the virus has been engineered to be resistant to drugs and vaccines, stated Richard H. Tullis, Ph.D., Aethlons Chief Scientific Officer.
Aethlon”s clinical goal is to develop the Hemopurifier as a countermeasure against smallpox and other viruses and toxins that are referenced in the U.S. government”s stated plan to acquire emergency stockpiles of treatments against candidate biological weapons. Project BioShield, which was signed into law on July 21,2004, authorizes $5.6 billion over 10 years to purchase and deploy new countermeasures against Smallpox, Anthrax, Ebola, Marburg, Plague, and other potential bioterror agents. Under Project BioShield, clinical efficacy for these bioweapons is established in animal models rather than in large-scale human trials. Aethlon believes that the Hemopurifier can serve as the first line of defense in treating drug and vaccine resistant biological weapons.
More Info:
World Health Orgnaization – Smallpox Info: http://www.who.int/topics/smallpox/en/
Project BioShield: a $5.6 Billion bill allocating funds over ten years for stockpiling new vaccines and developing countermeasures.
Additional HDS Homeland Security Related Web Sites:
www.BorderAndPortSecurity.com
www.NonLethalStocks.com
www.RFIDInvesting.com
HDS includes a growing list of public companies in the sector. Click here for a partial list of companies involved in homeland defense and security technology and solutions in Airport Security, Biodefense, Biometrics, Defense, Internet Security, Integrated Security, Military, Border and Port Security. http://www.HomelandDefenseStocks.com/Companies/HomelandDefense/Stock_List.asp
HomelandDefenseRadio.com is a 24-hour, national Internet station providing time-sensitive information to the homeland defense community. Hear HDS every Friday on this station: http://www.HomelandDefenseRadio.com/
HDS and BiodefenseStocks.com proudly introduces “The Insiders Corner, a weekly feature by well-known financial writer and author Michael Brush. http://investorideas.com/insiderscorner/ Read his recent article on biodfense:
Homeland Security Play May Rise on Bio-terror Defense Breakthroughs
http://www.biodefensestocks.com/insiderscorner/Articles/Bio-terror_Defense.asp
Sign-up for Our Free Investor Newsletter: http://investorideas.com/Resources/Newsletter.asp
BDS/HDS featured profiled biodefense, chemical detection companies:
Aethlon Medical, Inc. (OTCBB: AEMD) Biodefense – www.AethlonMedical.com – Pioneering the development of viral filtration devices to treat HIV/AIDS, Hepatitis-C (HCV and pathogens that are mass-casualty biological warfare candidates.
MDM Group, Inc. (OTC.PK: MDDM) www.mdmgroupinc.com – Non Lethal Weapons for Law Enforcement, Military and Anti-Terrorism and a recently launched biodefense division.
Markland Technologies, Inc. (OTCBB: MRKL) www.marklandtech.com – Has four business segments, which address the needs of the Homeland Security marketplace: Chemical Detectors, Border Security, Advanced Technologies and Sensing Technologies for the U.S. Army, the U.S. Navy, the Department of Homeland Security, and various other U.S. Intelligence agencies.
ECON is a privately owned corporate communications company specializing in: media relations, investor relations, and research on public companies and industry sectors, for the investment community. Nothing on our sites should be construed as an offer or solicitation to buy or sell any specific products or securities. All investments involve risk. Past performance does not guarantee future results, therefore investigate before you invest! Although we attempt to research thoroughly, we offer no guarantees as to the accuracy of any information presented. We encourage all investors to use our sites only as a resource to further their own research. The site is compensated by its Featured Companies, as outlined in our on-line disclaimer at www.InvestorIdeas.com/About/Disclaimer.asp. The site is currently compensated for by its featured companies.” Markland Technologies, Inc. currently pays ECON Ten Thousand Dollars per month. Markland has issued shares to ECON in the past and these payments are for the purpose of including Markland in articles and other promotions. Aethlon Medical, Inc.: Three Thousand Dollars per month plus restricted shares equivalent to Five Thousand Dollars per month. MDM Group, Inc.: Three Thousand Dollars per month, plus Twenty Thousand shares per month
HomelandDefenseStocks.com is a Registered WA Trade Name
For more information contact:
Dawn Van Zant / Trevor Ruehs
Toll free: 800-665-0411
Email: dvanzant@HomelandDefenseStocks.com, truehs@HomelandDefenseStocks.com
